Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Nature

• Publication date

  1997-05-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/387422A0PMID 9163430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Retinoblastoma Protein and Cell Cycle Control Review

  2004cited by this paper
• Functional analysis of E2F transcription factor.

  1997cited by this paper
• Cdc25 cell-cycle phosphatase as a target of c-myc

  1996cited by this paper
• Requirement of p27Kip1 for Restriction Point Control of the Fibroblast Cell Cycle

  1996cited by this paper
• E2F-induced S phase requires cyclin E.

  1996cited by this paper
• The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state

  1996cited by this paper
• A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation.

  1996cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• The transcription factor E2F is required for S phase during Drosophila embryogenesis.

  1995cited by this paper
• Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

  1995cited by this paper
• Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation

  1995cited by this paper
• Different roles for cyclins D1 and E in regulation of the G1-to-S transition

  1995cited by this paper
• Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression.

  1995cited by this paper
• E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity.

  1995cited by this paper
• Identification of a Myc‐dependent step during the formation of active G1 cyclin‐cdk complexes.

  1995cited by this paper
• Beating a path to Myc

  1995cited by this paper
• Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation.

  1995cited by this paper
• Signal transduction. Beating a path to Myc.

  1995cited by this paper
• Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein.

  1994cited by this paper
• lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin

  1994cited by this paper
• Function and regulation of ras.

  1993cited by this paper
• Effects of an Rb mutation in the mouse

  1992cited by this paper
• Dominant inhibitory mutations in the Mg(2+)-binding site of RasH prevent its activation by GTP

  1991cited by this paper
• Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP

  1988cited by this paper
• Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.

  1987cited by this paper
• Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells

  1985cited by this paper
• Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

  1983cited by this paper

• MYC as a Target for Cancer Treatment: from Undruggable to Druggable?

  2025cites this paper
• HIV infection reprogrammes CD4+ T cells for quiescence and entry into proviral latency

  2025cites this paper
• Oncogenic signaling in the Drosophila prostate-like accessory gland activates a pro-tumorigenic program in the absence of proliferation

  2025cites this paper
• Cyclin E1 as a driver of oncogenesis; high grade serous ovarian cancer as an exemplar.

  2025cites this paper
• Cellular transcriptomics of arrested normal lung fibroblasts IMR-90 infected with Human Adenovirus 5 E1A mutants

  2025cites this paper
• From Fundamentals to Innovation in Alzheimer’s Disease: Molecular Findings and Revolutionary Therapies

  2024cites this paper
• Oncogenic signaling in the adult Drosophila prostate-like accessory gland leads to activation of a conserved pro-tumorigenic program, in the absence of proliferation

  2024cites this paper
• MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer

  2024cites this paper
• Gene model for the ortholog of Myc in Drosophila eugracilis

  2024cites this paper
• Contaminants from dredged sediments alter the transcriptome of Manila clam and induce shifts in microbiota composition

  2023cites this paper
• The transcription factor EBF1 non-cell-autonomously regulates cardiac growth and differentiation

  2023cites this paper
• The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer

  2023cites this paper
• Wnt Signaling Pathway Collapse upon β-Catenin Destruction by a Novel Antimicrobial Peptide SKACP003: Unveiling the Molecular Mechanism and Genetic Activities Using Breast Cancer Cell Lines

  2023cites this paper
• Unraveling MYC’s Role in Orchestrating Tumor Intrinsic and Tumor Microenvironment Interactions Driving Tumorigenesis and Drug Resistance

  2023cites this paper
• Epigenetic alterations impede epithelial-mesenchymal transition by modulating centrosome amplification and Myc/RAS axis in triple negative breast cancer cells

  2023cites this paper
• TRAF4-mediated nonproteolytic ubiquitination of androgen receptor promotes castration-resistant prostate cancer

  2023cites this paper
• E2F1-induced lncRNA, EMSLR regulates lncRNA LncPRESS1

  2022cites this paper
• Activated Src requires Cadherin-11, Rac, and gp130 for Stat3 activation and survival of mouse Balb/c3T3 fibroblasts

  2022cites this paper
• Decoding the Phosphatase Code: Regulation of Cell Proliferation by Calcineurin

  2022cites this paper
• The CMG helicase and cancer: a tumor “engine” and weakness with missing mutations

  2022cites this paper
• An HIV-induced mechanism for T cell quiescence and proviral latency

  2021influential citation
• E2F Transcription Factors in Cancer, More than the Cell Cycle

  2021cites this paper
• Polyploidy in development and tumor models in Drosophila.

  2021cites this paper
• MYC dysfunction modulates stemness and tumorigenesis in breast cancer

  2021cites this paper
• Spatiotemporal control of pathway sensors and cross-pathway feedback regulate a differentiation MAPK pathway in yeast.

  2021cites this paper
• c-Myc-activated USP2-AS1 suppresses senescence and promotes tumor progression via stabilization of E2F1 mRNA

  2021cites this paper
• High G protein subunit beta 4 protein level is correlated to poor prognosis of urothelial carcinoma

  2021cites this paper
• Overexpression of Cyclin E1 or Cdc25A leads to replication stress, mitotic aberrancies, and increased sensitivity to replication checkpoint inhibitors

  2020cites this paper
• c‐Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation

  2020cites this paper
• E2F1 promotes cancer cell sensitivity to cisplatin by regulating the cellular DNA damage response through miR-26b in esophageal squamous cell carcinoma

  2020cites this paper
• Increased E2F1 mRNA and miR-17-5p Expression Is Correlated to Invasiveness and Proliferation of Pituitary Neuroendocrine Tumours

  2020cites this paper
• Impact of MYC on Anti-Tumor Immune Responses in Aggressive B Cell Non-Hodgkin Lymphomas: Consequences for Cancer Immunotherapy

  2020cites this paper
• AWARD NUMBER: W81XWH-15-1-0536 TITLE: TRAF4 and Castration-Resistant Prostate Cancer PRINCIPAL INVESTIGATOR: Ping Yi CONTRACTING ORGANIZATION: Baylor College of Medicine

  2020cites this paper
• Spatiotemporal Control of Pathway Sensors and Cross-Pathway Feedback Regulate a Cell Differentiation MAPK Pathway in Yeast

  2020cites this paper
• The requirement for cyclin E in c-Myc overexpressing breast cancers

  2020cites this paper
• Multi-parameter exploration of dynamics of regulatory networks

  2020cites this paper
• The Oncogenic Potential of the Centromeric Border Protein FAM84B of the 8q24.21 Gene Desert

  2020cites this paper
• ArticleIncreased E

  2020cites this paper
• YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner

  2020cites this paper
• Memory like NK cells display stem cell like properties after Zika virus infection

  2020cites this paper
• SMAD3 directly regulates cell cycle genes to maintain arrest in granulosa cells of mouse primordial follicles

  2019cites this paper
• Pro-senescence therapy by targeting MYC and its network as a strategy to combat cancer

  2019cites this paper
• The function of RAS mutation in cancer and advances in its drug research.

  2019cites this paper
• Cooperativity between MYC and other oncogenic factors : implications for tumorigenesis and targeting of MYC

  2019cites this paper
• Ironing out the role of the cyclin‐dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity

  2019cites this paper
• Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis

  2019cites this paper
• Non-Coding RNAs in Pediatric Solid Tumors

  2019cites this paper
• FAM84B promotes prostate tumorigenesis through a network alteration

  2019cites this paper
• Oncogenic MYC amplifies mitotic perturbations

  2019cites this paper
• Low E2F2 activity is associated with high genomic instability and PARPi resistance

  2019cites this paper
• Identification and characterization of small molecules targeting MYC function

  2019cites this paper
• The lysine acetyltransferase GCN5 contributes to human papillomavirus oncoprotein E7‐induced cell proliferation via up‐regulating E2F1

  2018cites this paper
• Centrosome aberrations and chromosome instability contribute to tumorigenesis and intra-tumor heterogeneity

  2018influential citation
• Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.

  2018cites this paper
• Effects of IKK/NF-κB signaling in MYC-driven liver tumorigenesis

  2018cites this paper
• ANP32E induces tumorigenesis of triple‐negative breast cancer cells by upregulating E2F1

  2018cites this paper
• Current understanding of the role and regulation of miRNAs in Burkitt lymphoma

  2018cites this paper
• Arsenic trioxide and all-trans-retinoic acid selectively exert synergistic cytotoxicity against FLT3-ITD AML cells via co-inhibition of FLT3 signaling pathways

  2017cites this paper
• BNIP3 upregulation via stimulation of ERK and JNK activity is required for the protection of keratinocytes from UVB-induced apoptosis

  2017influential citation
• CD47+ Exosomes Facilitate Effective Targeting of Oncogenic Kras in Pancreatic Cancer

  2017cites this paper
• Calcium signaling and cell cycle: Progression or death.

  2017cites this paper
• Investigating E2F independent cell cycle control and tumor suppression by pRB

  2017cites this paper
• Myc Cooperates with Ras by Programming Inflammation and Immune Suppression

  2017cites this paper
• Nujiangexathone A, a novel compound from Garcinia nujiangensis, suppresses cervical cancer growth by targeting hnRNPK.

  2016cites this paper
• Primary Salivary Human Stem/Progenitor Cells Undergo Microenvironment‐Driven Acinar‐Like Differentiation in Hyaluronate Hydrogel Culture

  2016cites this paper
• Tissue-Specific Progenitor and Stem Cells Primary Salivary Human Stem / Progenitor Cells Undergo Microenvironment-Driven Acinar-Like Differentiation in Hyaluronate Hydrogel Culture

  2016cites this paper
• Rab11, a vesicular trafficking protein, affects endoreplication through Ras-mediated pathway in Drosophila melanogaster

  2016cites this paper
• Role of nuclear constitutive androstane receptor in regulation of hepatocyte proliferation and hepatocarcinogenesis

  2016cites this paper
• Tumour promoting HER2 splice variant Δ16HER2: Regulation and implication in breast cancer

  2016cites this paper
• Principles of dynamical modularity in biological regulatory networks

  2016cites this paper
• The Quest for Targets Executing MYC-Dependent Cell Transformation

  2016cites this paper
• Increased metastasis with loss of E2F2 in Myc-driven tumors

  2015cites this paper
• The T-Box factor TBX3 is important in S-phase and is regulated by c-Myc and cyclin A-CDK2

  2015cites this paper
• Targeting E2F1 and c-Myc expression by microRNA-17-5p represses interferon-stimulated gene MxA in peripheral blood mononuclear cells of pediatric systemic lupus erythematosus patients.

  2015cites this paper
• Myc and cell cycle control.

  2015cites this paper
• The Nucleolar Protein GLTSCR2 Is an Upstream Negative Regulator of the Oncogenic Nucleophosmin-MYC Axis.

  2015cites this paper
• Elucidating the role of E2F2 loss in mediating human breast cancer metastasis

  2015cites this paper
• The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential

  2015cites this paper
• Redeployment of Myc and E2f1-3 drives Rb deficient cell cycles

  2015cites this paper
• Cell-cell and cell-matrix adhesion in survival and metastasis: Stat3 versus Akt

  2015cites this paper
• Oncogenic MicroRNAs: Key Players in Malignant Transformation

  2015cites this paper
• The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis

  2015cites this paper
• Journal of Pharmaceutical and Biological Sciences

  2015cites this paper
• MYC cofactors: molecular switches controlling diverse biological outcomes.

  2014cites this paper
• Challenges and Opportunities of MicroRNAs in Lymphomas

  2014cites this paper
• The HER2 Signaling Network in Breast Cancer—Like a Spider in its Web

  2014cites this paper
• ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells

  2014cites this paper
• WNT Signaling: an Emerging Mediator of Cancer Cell Metabolism?

  2014cites this paper
• Proliferation and Lineage Allocation Alters Hematopoietic Progenitor Cell

  2014cites this paper
• Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma.

  2014cites this paper
• Division of labour between Myc and G1 cyclins in cell cycle commitment and pace control

  2014cites this paper
• MicroRNA in carcinogenesis & cancer diagnostics: A new paradigm

  2013cites this paper
• The E2F1-miRNA cancer progression network.

  2013cites this paper
• The targeting and functions of miRNA-383 are mediated by FMRP during spermatogenesis

  2013cites this paper
• Proliferative und apoptotische Eigenschaften des Transkriptionsfaktors MYC

  2013cites this paper
• The Ciliary Protein Cystin Forms a Regulatory Complex with Necdin to Modulate Myc Expression

  2013cites this paper
• Identification and analysis of the regulatory network of Myc and microRNAs from high-throughput experimental data

  2013cites this paper
• Repression of miR-17-5p with elevated expression of E2F-1 and c-MYC in non-metastatic hepatocellular carcinoma and enhancement of cell growth upon reversing this expression pattern.

  2013cites this paper
• Changes in Protein Abundance are Essential for Proper Cell Cycle Regulation

  2013cites this paper
• Control of e2f1 and PCNA by Drosophila transcription factor DREF

  2013cites this paper